UCL Queen Square Institute of Neurology


ARUK UCL Drug Discovery Institute Seminar Series:  E. Stewart Geary

29 September 2023, 2:00 pm–4:00 pm

ARUK DDI banner

Lost & Gained in Translation: How a Clinical Safety Physician Interprets Drug Discovery & Early Toxicology Findings

Event Information

Open to





Sandra Porteous


Leolin Price Lecture Theatre
Guilford Street

We are delighted to invite you to this seminar on safety considerations in drug discovery and development followed by round table discussion by Dr. E. Stewart Geary, Global Safety Officer, Eisai Co. Ltd.  The talk will address how even minor safety observations in preclinical research can predict impact in later clinical development, the importance of drug class effects in safety and regulatory considerations. This will inform on how our preclinical research and toxicology data supports translation to the clinic.

About the Speaker

E. Stewart Geary

Global Safety Officer at Eisai Co

 E. Stewart Geary, MD, is Global Safety Officer at Eisai Co., Ltd. He is a Councilor of the Japanese Association of Pharmaceutical Medicine and serves on the Editorial Advisory Board for the Journal of Pharmaceutical Medicine. A member of CIOMS XII, he also served on the CIOMS VII Working Group on the Development Safety Update Report, CIOMS VIII on Signal Detection, CIOMS on Standardized MedDRA Queries, CIOMS IX on Medicinal Product Risk Management and CIOMS Working Group on Drug-Induced Liver Injury. Dr. Geary is a DIA Fellow, a Fellow of the Academy of Physicians in Clinical Research and an IFAPP Global Fellow in Medicines Development. He earned a BA from Harvard and MD from Stanford Medical School.